HEARTBEAM, INC. Restricted Cash and Cash Equivalents
HEARTBEAM, INC. (BEAT) had Restricted Cash and Cash Equivalents of $8.20 million as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2025-08-13
- 2025-03-31: Restricted Cash and Cash Equivalents $8.20M.
- 2024-12-31: Restricted Cash and Cash Equivalents $2.40M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2025-03-31 | $8.20M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.40M 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |